Arul Chinnaiyan
Arul Chinnaiyan
Arul Chinnaiyan is a Hicks Endowed Professor of Pathology and professor of pathology and urology at the University of Michigan Medical School. He is also a Howard Hughes medical Investigatorat the Howard Hughes Medical Institute...
benign determine elevated envision might patient physician replace suggest supplement test whether
Initially, we envision this new test could be used as a supplement to PSA. A physician might suggest a patient with an elevated PSA have this test before a biopsy to better determine whether it's a cancerous or benign condition. In the future, I think this could replace PSA.
envision supplement test
Initially, we envision this new test could be used as a supplement to PSA.
surprising
It was a serendipitous discovery, something very surprising to us.
allow best cancer ended
These 22 markers ended up being the best combination of markers that allow us to most effectively diagnose prostate cancer.
arena benign bulk cancer context disease expressed highly specific
It's a controversial arena -- the PSA is a marker of prostate bulk and size, but it's highly expressed in benign prostate disease as well as cancer -- so in that context it's not a specific marker.
advantage concept detect discovery immune study system taking
This was a discovery study that established the concept of taking advantage of the immune system to detect cancer.
agent evidence fusion gene intriguing particular
There is really intriguing evidence that this particular gene fusion is the causative agent of prostate cancer.